Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
HOCH Abgang Schlüsselpersonen (11.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 11.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | on 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoi |
| 04.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n 13(a) of the Exchange Act. ☐ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoint |
| 05.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | t forth by specific reference in such filing. Item 5.02 Departure of Directors or Certain Officers; Election of Direct |
| 05.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n 13(a) of the Exchange Act. ☐ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoint |
| 30.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | on 13(a) of the Exchange Act. ☐ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoin |
| 08.01.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | on 13(a) of the Exchange Act. ☐ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoin |
| 19.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | on 13(a) of the Exchange Act. ☐ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appoin |
| 31.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | on 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoi |
Stammdaten
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Unternehmen & Branche
| Name | BIO-TECHNE Corp |
|---|---|
| Ticker | TECH |
| CIK | 0000842023 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 09073M104 |
|---|---|
| ISIN | US09073M1045 |
| Typ | Common Stock |
| Marktkapitalisierung | 9,48 Mrd. USD |
| Beta | 1,49 |
| Dividendenrendite | 0,32 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-Q | 295,877,000 | 38,009,000 | 0.24 | 2,522,699,000 | 2,010,989,000 |
| 2025-09-30 | 10-Q | 286,555,000 | 38,185,000 | 0.24 | 2,526,148,000 | |
| 2025-06-30 | 10-K | 1,219,635,000 | 73,400,000 | 0.46 | 2,557,868,000 | |
| 2025-03-31 | 10-Q | 316,181,000 | 22,588,000 | 0.14 | 2,644,259,000 | 2,018,025,000 |
| 2024-12-31 | 10-Q | 297,031,000 | 34,890,000 | 0.22 | 2,670,424,000 | 2,078,492,000 |
| 2024-09-30 | 10-Q | 289,458,000 | 33,600,000 | 0.21 | 2,736,017,000 | 2,138,650,000 |
| 2024-06-30 | 10-K | 1,159,060,000 | 168,105,000 | 1.05 | 2,703,867,000 | 2,068,850,000 |
| 2024-03-31 | 10-Q | 303,428,000 | 49,059,000 | 0.31 | 2,721,170,000 | 2,014,375,000 |
| 2023-12-31 | 10-Q | 272,598,000 | 27,465,000 | 0.17 | 2,730,753,000 | 1,963,559,000 |
| 2023-09-30 | 10-Q | 276,935,000 | 50,993,000 | 0.31 | 2,755,360,000 | 1,997,746,000 |
| 2023-06-30 | 10-K | 1,136,702,000 | 285,263,000 | 1.76 | 2,638,692,000 | 1,966,516,000 |
| 2023-03-31 | 10-Q | 294,146,000 | 70,218,000 | 0.43 | 2,599,696,000 | 1,889,686,000 |
| 2022-12-31 | 10-Q | 271,581,000 | 50,005,000 | 0.31 | 2,363,401,000 | 1,827,106,000 |
| 2022-09-30 | 10-Q | 269,655,000 | 89,555,000 | 0.55 | 2,350,721,000 | 1,751,154,000 |
| 2022-06-30 | 10-K | 1,105,599,000 | 272,051,000 | 1.66 | 2,294,805,000 | 1,701,770,000 |
| 2022-03-31 | 10-Q | 290,376,000 | 60,739,000 | 0.37 | 2,299,892,000 | 1,714,376,000 |
| 2021-12-31 | 10-Q | 269,276,000 | 80,173,000 | 0.49 | 2,304,846,000 | 1,702,989,000 |
| 2021-09-30 | 10-Q | 257,719,000 | 69,615,000 | 1.69 | 2,270,187,000 | 1,639,365,000 |
| 2021-06-30 | 10-K | 931,032,000 | 140,410,000 | 0.87 | 2,262,957,000 | 1,562,971,000 |
| 2021-03-31 | 10-Q | 243,552,000 | 45,782,000 | 1.12 | 2,084,642,000 | 1,539,453,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 17,810,878 | 0 | 17,810,878 | 1,047,457,735 | Neu | +100,0% | |
| BlackRock, Inc. | 12,129,125 | 0 | 12,129,125 | 713,313,819 | Neu | +100,0% | |
| MORGAN STANLEY | 8,345,414 | 0 | 8,345,414 | 490,794,044 | Neu | +100,0% | |
| STATE STREET CORP | 5,812,032 | 0 | 5,812,032 | 341,805,602 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 5,734,049 | 0 | 5,734,049 | 337,219,422 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 4,929,801 | 0 | 4,929,801 | 289,502,286 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 4,012,818 | 0 | 4,012,818 | 235,993,825 | Neu | +100,0% | |
| MAVERICK CAPITAL LTD | 3,850,923 | 0 | 3,850,923 | 226,472,782 | Neu | +100,0% | |
| Invesco Ltd. | 3,678,659 | 0 | 3,678,659 | 216,341,937 | Neu | +100,0% | |
| Neuberger Berman Group LLC | 3,129,334 | 0 | 3,129,334 | 184,036,113 | Neu | +100,0% | |
| Select Equity Group, L.P. | 2,837,142 | 0 | 2,837,142 | 166,852,321 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 2,798,437 | 0 | 2,798,437 | 164,576,211 | Neu | +100,0% | |
| MACKENZIE FINANCIAL CORP | 2,414,165 | 0 | 2,414,165 | 142,444,643 | Neu | +100,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2,398,265 | 0 | 2,398,265 | 141,041,965 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 2,364,845 | 0 | 2,364,845 | 139,076,534 | Neu | +100,0% | |
| UBS Group AG | 2,224,263 | 0 | 2,224,263 | 130,808,907 | Neu | +100,0% | |
| RGM Capital, LLC | 2,152,052 | 0 | 2,152,052 | 126,562,178 | Neu | +100,0% | |
| Durable Capital Partners LP | 2,088,891 | 0 | 2,088,891 | 122,847,680 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 1,928,485 | 0 | 1,928,485 | 113,414,203 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 1,794,293 | 0 | 1,794,293 | 105,523,778 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,692,842 | 0 | 1,692,842 | 99,556,044 | Neu | +100,0% | |
| NORGES BANK | 1,691,780 | 0 | 1,691,780 | 99,493,582 | Neu | +100,0% | |
| Capital Research Global Investors | 1,618,882 | 0 | 1,618,882 | 95,206,450 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,559,144 | 0 | 1,559,144 | 91,693,259 | Neu | +100,0% | |
| BROWN ADVISORY INC | 1,544,528 | 0 | 1,544,528 | 90,833,688 | Neu | +100,0% | |
| Champlain Investment Partners, LLC | 1,403,769 | 0 | 1,403,769 | 82,555,655 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1,332,200 | 0 | 1,332,200 | 78,346,682 | Neu | +100,0% | |
| BAMCO INC /NY/ | 1,207,499 | 0 | 1,207,499 | 71,013,016 | Neu | +100,0% | |
| Madison Asset Management, LLC | 1,181,308 | 0 | 1,181,308 | 69,472,749 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 1,137,315 | 0 | 1,137,315 | 66,885,517 | Neu | +100,0% | |
| Stephens Investment Management Group LLC | 1,109,658 | 0 | 1,109,658 | 65,258,987 | Neu | +100,0% | |
| GENEVA CAPITAL MANAGEMENT LLC | 1,090,495 | 0 | 1,090,495 | 64,132,012 | Neu | +100,0% | |
| Quantinno Capital Management LP | 1,019,342 | 0 | 1,019,342 | 59,947,524 | Neu | +100,0% | |
| FMR LLC | 1,014,961 | 0 | 1,014,961 | 59,689,871 | Neu | +100,0% | |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 994,330 | 0 | 994,330 | 58,476,547 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 984,420 | 0 | 984,420 | 57,893,740 | Neu | +100,0% | |
| Clearbridge Investments, LLC | 948,512 | 0 | 948,512 | 55,782,010 | Neu | +100,0% | |
| WEITZ INVESTMENT MANAGEMENT, INC. | 802,950 | 0 | 802,950 | 47,221,490 | Neu | +100,0% | |
| RIVERBRIDGE PARTNERS LLC | 785,788 | 0 | 785,788 | 46,212,174 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 759,082 | 0 | 759,082 | 44,641,657 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 746,801 | 0 | 746,801 | 44,046,954 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 703,477 | 0 | 703,477 | 41,372,740 | Neu | +100,0% | |
| Ceredex Value Advisors LLC | 688,321 | 0 | 688,321 | 40,480,158 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 684,009 | 0 | 684,009 | 40,226,570 | Neu | +100,0% | |
| ROYCE & ASSOCIATES LP | 678,502 | 0 | 678,502 | 39,902,703 | Neu | +100,0% | |
| CRAMER ROSENTHAL MCGLYNN LLC | 654,470 | 0 | 654,470 | 38,489,381 | Neu | +100,0% | |
| Caption Management, LLC | 562,400 | 0 | 562,400 | 33,074,744 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 557,529 | 0 | 557,529 | 32,788,000 | Neu | +100,0% | |
| TUDOR INVESTMENT CORP ET AL | 518,129 | 0 | 518,129 | 30,471,166 | Neu | +100,0% | |
| SEGALL BRYANT & HAMILL, LLC | 486,009 | 0 | 486,009 | 28,582,176 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | Herr Amy E. | Director | Open Market Sale | -1,976 | 59.11 | -116,791.48 | -22,3% | |
| 2025-08-25 | BAUMGARTNER ROBERT V | Director | Open Market Sale | -17,040 | 56.21 | -957,818.40 | -182,6% | |
| 2025-08-25 | Nusse Roeland | Director | Open Market Sale | -17,040 | 56.36 | -960,388.03 | -183,0% | |
| 2025-06-09 | Herr Amy E. | Director | Open Market Sale | -1,280 | 49.77 | -63,704.83 | -12,1% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-31 | 98.051 | 52,04 | 5.102.574 |
| 2026-03-30 | 619 | 50,95 | 31.538 |
| 2026-03-27 | 3.437 | 52,70 | 181.130 |
| 2026-03-26 | 232 | 52,69 | 12.224 |
| 2026-03-25 | 312 | 52,43 | 16.358 |
| 2026-03-24 | 381 | 52,00 | 19.812 |
| 2026-03-23 | 1.532 | 51,48 | 78.867 |
| 2026-03-20 | 9.464 | 51,59 | 488.248 |
| 2026-03-17 | 23.083 | 48,81 | 1.126.681 |
| 2026-03-11 | 158 | 52,82 | 8.346 |
| 2026-03-10 | 1.943 | 54,87 | 106.612 |
| 2026-03-09 | 20 | 53,89 | 1.078 |
| 2026-03-06 | 43.857 | 55,89 | 2.451.168 |
| 2026-03-03 | 19.948 | 57,82 | 1.153.393 |
| 2026-02-25 | 11.838 | 57,60 | 681.869 |
| 2026-02-23 | 653 | 57,52 | 37.561 |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| GAGNON SECURITIES LLC | 9,879 | 516,277 | 59.63 |
| OPPENHEIMER & CO INC | 5,132 | 268,198 | 30.98 |
| West Financial Advisors, LLC | 1,556 | 81,317 | 9.39 |